Tsunoda, I <br/><br/>
Lipopeptide particles as the immunologically active component of CTL inducing vaccines.  [electronic resource] 

 -  Vaccine  Feb 1999 
 - 675-85 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/s0264-410x(98)00250-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Animals<br/>Epitopes, T-Lymphocyte--immunology<br/>Female<br/>H-2 Antigens--metabolism<br/>Histocompatibility Antigens Class II--metabolism<br/>Influenza Vaccines--immunology<br/>Lipoproteins--immunology<br/>Lymphocyte Activation--immunology<br/>Mast-Cell Sarcoma<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, Inbred DBA<br/>Molecular Sequence Data<br/>Nucleocapsid Proteins<br/>Nucleoproteins--immunology<br/>Ovalbumin--immunology<br/>Particle Size<br/>Peptide Fragments--immunology<br/>RNA-Binding Proteins<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Tumor Cells, Cultured<br/>Viral Core Proteins--immunology